The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2026

Filed:

Jun. 09, 2021
Applicant:

Alkahest Inc., San Carlos, CA (US);

Inventors:

Bartosz Sikorski, Bydgoszcz, PL;

Elizabeth W. Jeffords, San Carlos, CA (US);

Erin Mccaskill Newman, San Carlos, CA (US);

Jessica A. Powell, San Carlos, CA (US);

Esther Rawner, San Carlos, CA (US);

Assignee:

ALKAHEST INC., San Carlos, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2006.01); A61K 31/4545 (2006.01); A61P 27/02 (2006.01);
U.S. Cl.
CPC ...
C07K 16/22 (2013.01); A61K 31/4545 (2013.01); A61P 27/02 (2018.01);
Abstract

The disclosure provides a method of reducing the frequency of administration of an anti-VEGF agent to a subject diagnosed with wet age-related macular degeneration. The method comprises administering a CCR3 inhibitory agent to the subject; administering the anti-VEGF agent to the subject after the administering of the CCR3 inhibitory agent; and administering additional subsequent doses of the anti-VEGF agent to the subject at a frequency less than the recommended frequency. The disclosure further provides a method of treating a subject suffering from a retina-associated disease, the method comprising administering an anti-VEGF agent to a subject suffering from a retina-associated disease and previously treated with a CCR3 inhibitory agent, wherein the anti-VEGF agent is administered at a frequency less than the recommended frequency for the anti-VEGF agent.


Find Patent Forward Citations

Sikorski, Bartosz. (2026). Methods of improving retina-associated disease outcome using ccr3-inhibitors (U.S. Patent No. 12692301). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12692301

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…